Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Several ASX-listed healthcare companies with low market caps are making strides in tackling cancer,  a leading cause of death ...

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...

A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...

A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

Pancragen, a synthetic tetrapeptide bioregulator, has garnered attention for its prospective impacts on pancreatic function and metabolic regulation. This article delves into the hypothesized ...